Advertisement

European Journal of Clinical Pharmacology

, Volume 18, Issue 6, pp 489–495 | Cite as

Effect of probenecid on excretion and natriuretic action of furosemide

  • F. Andreasen
  • B. Sigurd
  • E. Steiness
Original

Summary

Furosemide and inulin were given simultaneously by intravenous infusion to nine subjects over 2 h. The concentrations of sodium and of the two drugs in serum (free and protein bound) and in urine were followed during the infusion. In 6 male subjects the investigation was repeated after 3 days of oral treatment with probenecid 500 mg twice daily. Probenecid reduced the average ratio furosemide clearance/inulin clearance from 0.92 to 0.44. In experiments in which no probenecid had been given an average of 2% of the furosemide in urine was excreted by glomerular filtration. In vitro studies showed that the protein binding of furosemide was decreased in the presence of probenecid. The displacing effect of probenecid was confirmed in vivo, and during probenecid treatment glomerular filtration produced an average of 8% of the furosemide excreted by the kidney. The fraction of furosemide excreted by tubular secretion decreased during probenecid treatment from 98.0±0.6% to 91.7±5.6% (p<0.05). Prior to administration of probenecid, the fraction of the filtered sodium recovered from the urine during furosemide administration was 24.7%. Probenecid reduced that fraction to 21.0% (p<0.05). The excretion rate of furosemide appeared to be a better predictor of the natriuretic effect than its plasma concentration. Probenecid caused a significant change (p<0.05) in the regression line relating the log plasma concentration to the natriuretic effect, but it had no effect on the regression line relating the log urinary excretion rate of furosemide to its natriuretic effect. Although the decrease in the furosemide excretion rate during probenecid treatment averaged 25%, the sodium excretion rate was reduced by less than 15%. It is suggested that the natriuretic effect of furosemide is more pronounced if the furosemide molecules enter the tubular lumen at a more proximal level, and it is strongest if they do so by filtration through the glomerulus.

Key words

furosemide probenecid protein binding natriuretic interaction diuretic effect 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andreasen F, Mikkelsen E (1977) Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 12:15–22PubMedGoogle Scholar
  2. Andreasen F, Lederballe Pedersen O, Mikkelsen E (1978) Distribution, elimination and natriuretic effect of furosemide in patients with severe arterial hypertension. Eur J Clin Pharmacol 14:237–244PubMedGoogle Scholar
  3. Andreasen F, Husted S (1980) The binding of furosemide to serum proteins in elderly patients: Displacing effect of phenprocoumon. Acta Pharmacol Toxicol (in press)Google Scholar
  4. Beerman B, Dalén E, Lindström B (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 22:70–78PubMedGoogle Scholar
  5. Benet LZ (1979) Pharmacokinetics/Pharmacodynamics of furosemide in man: A review. J Pharmacokinet Biopharm 7:1–27PubMedGoogle Scholar
  6. Brater DC (1978) Effects of probenecid on furosemide response. Clin Pharmacol Ther 24:548–554PubMedGoogle Scholar
  7. Burg M, Stoner LC, Cardinal J, Green N (1973) Furosemide effect on isolated perfused tubules. Am J Physiol 225:119–124PubMedGoogle Scholar
  8. Deetjen P (1966) Micropuncture studies on site and modes of diuretic action of furosemide. Ann NY Acad Sci 139:408–415Google Scholar
  9. Hajdú P, Häussler A (1964) Untersuchungen mit dem Salidiureticum 4-Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneim Forsch 14:709–710Google Scholar
  10. Heyrovsky A (1956) A new method for the determination of inulin in plasma and urine. Clin Chim Acta 1:470–477PubMedGoogle Scholar
  11. Homeida M, Roberts C, Branch RA (1977) Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man. Clin Pharmacol Ther 22:402–409PubMedGoogle Scholar
  12. Honari J, Blair AD, Cutler RE (1977) Effects of probenecid on furosemide kinetics and natriuresis in man. Clin Pharmacol Ther 22:R 395–401PubMedGoogle Scholar
  13. Mikkelsen E, Andreasen F (1977) Simultaneous determination of furosemide and two of its possible metabolites in biological fluids. Acta Pharmacol Toxicol 41:254–262Google Scholar
  14. Prandota J, Pruitt AW (1974) Furosemide binding to human albumin and plasma of nephrotic children. Clin Pharmacol Ther 17:159–166Google Scholar
  15. Weder HG, Schildknecht J, Kesselring P (1971) A new equilibrium dialyzing system. Am Lab 10:15–21Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • F. Andreasen
    • 1
    • 2
    • 3
  • B. Sigurd
    • 1
    • 2
    • 3
  • E. Steiness
    • 1
    • 2
    • 3
  1. 1.Division of Clinical Pharmacology, Institute of PharmacologyUniversity of AarhusAarhusDenmark
  2. 2.Medical Department BRigshospitaletCopenhagenDenmark
  3. 3.Department of PharmacologyUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations